News Focus
News Focus
Followers 56
Posts 8449
Boards Moderated 0
Alias Born 05/14/2015

Re: Tonneke post# 69615

Thursday, 06/24/2021 10:12:18 AM

Thursday, June 24, 2021 10:12:18 AM

Post# of 118623
Don't you think it is important to know that the molecules that Regen used are no longer available to them as Lilly shut down their OIDD program in early 2019. It is why you stopped hearing about it. What ever Regen found ended up being of no interest to Lilly as the OIDD program allowed for further collaboration if Lilly though Regen found something ground breaking.

I already posted about this but seems that there is more currency in hyping old, no longer valid press releases of things no longer being done than the actual truth of what is really happening.

Lilly closed the doors on their OIDD program and Regen in 2019.


I am 100% sure that Koos will confirm this.

If you need confirmation, here's Lilly's website of the program that Regen was using to screen lilly's library of molecules, molecules they no longer have access to. The website was SHUT DOWN along with the program. UNDENIABLE!

https://openinnovation.lilly.com/dd/

and from a research paper on the subject

This is particularly pointed when considering the case of Eli Lilly
& Co. a pioneer of open innovation, with their early entry into,
and success with, the Open Innovation and Drug Discovery
(OIDD) platform, but for which seemingly no trace is now found
online, despite numerous earlier publications and an open way of
documenting available web resources [12,16,17] (e.g.: https://
openinnovation.lilly.com/dd/what-we-offer/).



https://bio.mx/wp-content/uploads/2021/01/DDT_2020_12_01_Crowdsourcing.pdf

FACTS are stubborn things

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y